AdaptHealth Corp.

NASDAQ:AHCO

Medical - Devices

Healthcare
$7.37 +0.10%

+$0.01 today

Market cap
$1.01B
Beta
1.46
P/E (TTM)
-16.3
EPS (TTM)
-$0.59
52W Low $8.06High $13.43

Volume 1.54M

Average 1.38M

AHCO Pre-Tax Margin

Income before tax as a percentage of revenue.

AdaptHealth Corp.NASDAQ: AHCO

Pre-Tax Margin · Q1 FY2026 · quarter ended Apr 2026

Pre-tax margin narrows to -2.5%

Pre-tax margin was -2.5% in Q1 FY2026, down 1.6 pp from a year earlier. On a trailing-twelve-month basis it was -1.0%, down 5.8 pp year over year. Over 3 fiscal years it narrowed by 3.8 pp.

Context

  • Pre-tax margin widened in 1 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterApr 2026
-2.5%+9.1 pp QoQ
Last fiscal yearDec 2025
-0.5%-4.6 pp YoY
LTMApr 2026
-1.0%-5.8 pp YoY
Pre-Tax Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-1.6 pp——
1 year-4.6 pp——
3 years-3.8 pp——
5 years——
10 years——

Pre-Tax Margin history

Percent of revenue · from the income statement

Latest · FY2025
-0.5%
Year-over-year change
-4.6pp

Pre-Tax Margin vs competitors

How AHCO compares with its peers on the latest reported figures

  • AHCO's LTM Apr 2026 pre-tax margin of -1.0% is the 6th highest of the 9 companies compared; the peer median is 7.7%.
  • Its year-over-year change of -5.8 pp is the lowest of 9, against a peer median of +2.3 pp.
  • Over three fiscal years its change of -3.8 pp compares with a peer median of +8.4 pp.
AHCO Competitors Peer median
Pre-Tax Margin for AHCO and competitors
Company Period LTM level YoY 3-year change
RMDResMed Inc.LTM Jun 202634.0% +1.4 pp+7.9 pp
ELMDElectromed, Inc.LTM Mar 202618.9% +3.3 pp+8.9 pp
INFUInfuSystem Holdings, Inc.LTM Mar 20268.3% +3.5 pp+7.3 pp
INSPInspire Medical Systems, Inc.LTM Jun 20267.7% +0.9 pp+18.1 pp
VMDViemed Healthcare, Inc.LTM Mar 20267.7% +0.1 pp+1.6 pp
AHCOAdaptHealth Corp.LTM Apr 2026-1.0% -5.8 pp-3.8 pp
INGNInogen, Inc.LTM Mar 2026-7.3% +1.0 pp+15.4 pp
TNDMTandem Diabetes Care, Inc.LTM Mar 2026-9.5% +6.3 pp-8.1 pp
BBNXBeta Bionics, Inc.LTM Mar 2026-60.3% +41.4 pp+36100.7 pp
Peer median (excluding AHCO) 7.7%+2.3 pp+8.4 pp

Competitors are the stored peer set for AHCO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.45B2.97B3.2B3.26B3.24B
Cost of Revenue2.01B2.55B2.52B2.58B2.68B
Gross Profit445.61M417.43M681.77M681.09M568.56M
Gross Margin18.2%14.1%21.3%20.9%17.5%
Research & Development00000
Selling, General & Admin167.51M162.13M190.09M359.24M382.29M
Operating Expenses220.01M227.02M1.28B417.36M382.29M
Depreciation & Amortization258.05M423.44M420.59M365.33M413.04M
EBITDA544.21M630.76M(171.09M)628.02M503.64M
EBITDA Margin22.2%21.2%-5.3%19.3%15.5%
Operating Income225.61M190.41M(598.4M)263.73M186.27M
Operating Margin9.2%6.4%-18.7%8.1%5.7%
Interest Income00000
Interest Expense95.2M109.41M130.3M126.67M105.75M
Other Income / Expenses(34.65M)(92.51M)(125.38M)(127.71M)(201.42M)
Income Before Tax190.96M97.9M(723.78M)136.02M(15.15M)
Pre-Tax Margin7.8%3.3%-22.6%4.2%-0.5%
Income Tax Expense32.81M24.77M(49M)41.24M50.88M
Net Income156.18M69.32M(678.9M)90.42M(70.79M)
Net Margin6.4%2.3%-21.2%2.8%-2.2%
EPS (Basic)1.120.52(5.32)0.62(0.52)
EPS (Diluted)0.670.50(5.31)0.61(0.52)
Weighted Avg Shares126.31M134.18M134.16M133.76M135.15M
Weighted Avg Shares (Diluted)133.03M138.99M134.42M135.53M135.15M

AdaptHealth Corp.

NASDAQ:AHCO

Intrinsic Alpha fair value

Locked

Current Price

$7.37

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.